RePub Publications from Erasmus University, Rotterdam
-
An Overview of Models and Techniques for Integrating Vehicle and Crew Scheduling Book Chapter
R. Freling (Richard), A.P.M. Wagelmans (Albert) and J.M. Pinto Paixão (José)
January 1999
-
GATA-3 is involved in the development of serotonergic neurons in the caudal raphe nuclei Article
The Journal of Neuroscience, 19(12), 1-8.J. van der Wees (Jacqueline), A. Karis (Alar), E. Goedknegt (Erika), M. Rutteman (Mandy), F.G. Grosveld (Frank), J.H. van Doorninck (Hikke) and C.I. de Zeeuw (Chris)
January 1999
-
Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Article
European Journal of Immunology, 29(6), 1912-1918.R.W. Hendriks (Rudi), M.C. Nawijn (Martijn), J.D. Engel (Douglas), F.G. Grosveld (Frank), A. Karis (Alar) and J.H. van Doorninck (Hikke)
January 1999 -
The transcription factor GATA3 is a downstream effector of Hoxb1 specification in rhombomere 4 Article
Development (Cambridge), 5523-5531.I. Pata (Illar), M. Studer (Michèle), J.H. van Doorninck (Hikke), J. Briscoe (James), S. Kuuse (Sulev), J.D. Engel (Douglas), F.G. Grosveld (Frank) and A. Karis (Alar)
January 1999
-
The success of marketing management support systems Article
Marketing Science: the marketing journal of INFORMS, 18(3), 196-207.B. Wierenga (Berend), G.H. van Bruggen (Gerrit) and R. Staelin
January 1999 -
The explanation of medical concepts by expert physicians, clerks and advanced students Article
Teaching and Learning in Medicine: an international journal, 11(3), 153-163.M.W.J. van de Wiel (Margje), H.P.A. Boshuizen (Henny) and H.G. Schmidt (Henk)
January 1999 -
The revised version of the Screen for Child Anxiety Related Emotional Disorders (SCARED-R): Factor structure in normal children Article
Personality and Individual Differences, 26(1), 99-112.P.E.H.M. Muris (Peter), H. Merckelbach (Harald), H.G. Schmidt (Henk) and B.N. Mayer (Birgit)
January 1999 -
Increased loss of trabecular but not cortical bone density, 1 year after discontinuation of 2 years hormone replacement therapy with Tibolone Article
Maturitas, 31(2), 151-159.B. Berning (Bernd), C. van Kuijk (Cornelis), J.-W. Kuiper (Jan-Willem), H.J.T. Coelingh-Bennink (H. J T) and B.C.J.M. Fauser (Bart)
January 1999